> A Florida hospital has sued Astellas Pharma over Adenoscan, a drug given to people unable to run on a treadmill during cardiac stress tests, because the drugmaker argues hospitals would violate a ...

JERUSALEM — Teva Pharmaceutical Industries has become the first to launch a generic drug for treating certain heart patients, the company said. Teva announced the launch of adenosine injection, a ...

Add Yahoo as a preferred source to see more of our stories on Google. The headquarters of Japanese pharmaceutical company Astellas Pharma Inc. is seen in Tokyo July 17, 2009. REUTERS/Stringer By Toni ...

The U.S. Food and Drug Administration has issued a warning that there is a rare but serious risk of heart attack or death associated with the use of cardiac nuclear stress test agents Lexiscan ...

FDA: Stress Test Agents Linked to Possible Heart Attack, Death The FDA is warning healthcare professionals of the rare but serious risk of heart attack and death associated with the use of Lexiscan ...

WASHINGTON, Nov. 20 (UPI) -- The U.S. Food and Drug Administration warns doctors of the rare but serious risk of heart attack and death with use of the cardiac nuclear stress test agents. The cardiac ...

Astellas Pharma, King Pharmaceuticals (KG) and Teva Pharmaceutical Industries (TEVA) announce that US subsidiaries of Astellas, along with Item Development A.B and KB have executed settlement ...

The U.S. Food and Drug Administration warned physicians on Wednesday that two chemicals used to conduct cardiovascular stress tests can cause heart attacks and death, and it suggested resuscitation ...